2016-03-31
Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma
Publication
Publication
Haematologica , Volume 101 - Issue 4 p. e149- e152
Additional Metadata | |
---|---|
, , , | |
doi.org/10.3324/haematol.2015.132431, hdl.handle.net/1765/91962 | |
Haematologica | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Broijl, A, Kersten, M.J, Alemayehu, W.G, Levin, M.-D, de Weerdt, O, Vellenga, E, … Sonneveld, P. (2016). Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma. Haematologica, 101(4), e149–e152. doi:10.3324/haematol.2015.132431
|